XL-PROTEIN
Live / Registered — Registered (as of 18 Jan 2022)
What this means for you
Registered since 18 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79289202
- Registration number
- 6617137
- Mark type
- Stylized text
- Filed
- 18 May 2020
- Published for opposition
- 02 Nov 2021
- Registered
- 18 Jan 2022
- Attorney of record
- Anthony G. Craig
Goods and services
- Class 001 — Chemicals: Chemical and biochemical preparations for use in biochemical research laboratories, in chemical research laboratories, in biotechnological research laboratories or in pharmaceutical research laboratories, other than for medical and veterinary use, as well as for industrial and scientific use
- Class 005 — Pharmaceuticals: Pharmaceutical, medical and veterinary preparations for the treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases or bone diseases; Pharmaceutical preparations for the treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, or bone diseases and diagnostic reagents for use in medicine and dentistry; Test kit reagents for use in medicine and dentistry; Chemical, biochemical and biotechnological preparations for medical and diagnostic use, namely reagents for medical purposes and solvents for sample preparation, modification and manipulation of cells as well as for use in methods for labeling, separation, isolation, purification, multiplication and analysis of biopolymers, especially nucleic acids, proteins, macromolecules and biologically active substances for medical diagnostic use; Drugs for preventive, curative and palliative purposes, namely for the treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, or bone diseases; Diagnostic medical biomarkers, especially for preventive, diagnostic, prognostic or predictive use; Medical preparations, namely, kits for use in medical laboratories, especially for preventive, diagnostic, prognostic or predictive use composed of proteinaceous reagents for medical purposes; Biomolecules for medical use, namely, for binding of active agents in the field of treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, or bone diseases; Medical preparations for use in medical diagnostic for the treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, or bone diseases; Chemical and biological preparations for medical and diagnostic purposes for the treatment of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, or bone diseases
- Class 042 — Scientific and technological services: Scientific and technological services and research, namely, scientific research, analysis, and testing, and research all in the field of chemistry, genetics, biology, biotechnology and biochemistry; Medical or scientific laboratory services, namely, testing services in the field of DNA, RNA as well as protein expression, detection and analysis and design relating thereto, especially in the field of chemistry, genetics, biology, biotechnology and biochemistry; Services of a chemical and biochemical scientific or medical laboratory; Technological services, namely, technical processing in the nature of product development and technical scientific analysis of biomaterials and medically relevant data especially for scientific and industrial research
Owner
- XL-protein GmbH, DE
- XL-protein GmbH, DE
- XL-protein GmbH, DE
Prosecution history
- 18 Jul 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 27 Jun 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 27 Jun 2022 — FINAL DISPOSITION PROCESSED
- 18 Apr 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 18 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
- 01 Jan 2022 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 15 Dec 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 15 Dec 2021 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 08 Nov 2021 — NOTIFICATION PROCESSED BY IB
- 02 Nov 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Nov 2021 — PUBLISHED FOR OPPOSITION
- 13 Oct 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 13 Oct 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 13 Oct 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Sept 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER